Certified by Founder Lodge
Hatteras Venture Partners
United States - Durham, NC
INVESTOR
1 Disclosed Funding Rounds $15,100,000
13 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Hatteras Venture Partners is a venture capital firm that builds transformational companies in the areas of biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related opportu
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 09 ,2022 | Series A | $15,100,000.00 |
| Company | Date | Round | Raised |
|---|---|---|---|
Cardiosense |
December, 09 ,2022 | Series A | $15,100,000 |
Mercy BioAnalytics, Inc. |
April, 04 ,2023 | Series A | $41,000,000 |
Aer Therapeutics, Inc. |
April, 17 ,2023 | Series A | $36,000,000 |
Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
Ten63 Therapeutics |
June, 16 ,2023 | Series A | $5,190,000 |
Elligo Health Research |
October, 03 ,2023 | Unknown | $40,000,000 |
iVEAcare, Inc. |
April, 23 ,2024 | Series A | $27,500,000 |
AtaCor Medical, Inc. |
April, 25 ,2024 | Series C | $28,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
Sensorium Therapeutics |
September, 03 ,2025 | Series A | $25,000,000 |
Boomerang Medical |
September, 04 ,2025 | Series B | $20,000,000 |
CREATE Medicines |
May, 14 ,2026 | Series B | $122,000,000 |
Cardiosense
Mercy BioAnalytics, Inc.
Aer Therapeutics, Inc.
Myeloid Therapeutics
Ten63 Therapeutics
Elligo Health Research
iVEAcare, Inc.
AtaCor Medical, Inc.
Endogenex
Atsena Therapeutics
Sensorium Therapeutics
Boomerang Medical
CREATE Medicines
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Ranger AI | $8,400,000 | (May 15, 2026)
Graphon AI | $8,300,000 | (May 15, 2026)
Iceotope | $26,000,000 | (May 15, 2026)
Wirestock | $23,000,000 | (May 15, 2026)
Chromie Health | $2,000,000 | (May 15, 2026)